Stock KINDER HOLDING CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Kinder Holding Corp OTC Bulletin Board

Equities

US4945261067

Pharmaceuticals

Business Summary

Nexien BioPharma, Inc. is engaged in pre-clinical and drug development activities for certain pharmaceutical formulations that include cannabinoids. The Company is focused on developing and commercializing United States Food and Drug Administration (FDA)-compliant cannabinoid pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders and medical conditions. Its flagship research and development programs are focused on advancing formulations that have the potential to improve the treatment outcomes of certain convulsive disorders and neuromuscular disorders, which includes the treatment of myotonic dystrophy. The Company's wholly owned subsidiaries include Intiva BioPharma Inc., NexN Inc. (NexN) and NexDM Inc.

Managers

Managers TitleAgeSince
Richard Greenberg CEO
 Chief Executive Officer 75 14-01-31
Evan Wasoff DFI
 Director of Finance/CFO 77 -
Jeremy Reeh CTO
 Chief Tech/Sci/R&D Officer - 18-10-25
Robert Goldfarb COO
 Chief Operating Officer 69 -
Frank Manganella PRN
 Corporate Officer/Principal 58 18-10-29
Joseph Aceto PRN
 Corporate Officer/Principal 66 18-10-29

Members of the board

Members of the board TitleAgeSince
Lindy Snider BRD
 Director/Board Member 64 18-01-25
Richard Greenberg CEO
 Chief Executive Officer 75 14-01-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 67,472,196 30,966,703 ( 45.90 %) 0 45.90 %

Shareholders

NameEquities%Valuation
Kanativa USA, Inc.
28.16 %
19,000,000 28.16 % 304 000 $
Richard Greenberg
9.167 %
6,185,193 9.167 % 98 963 $
Evan Wasoff
6.669 %
4,500,000 6.669 % 72 000 $
Alex Wasyl
5.649 %
3,811,500 5.649 % 60 984 $
Robert Goldfarb
3.376 %
2,278,000 3.376 % 36 448 $
Lindy Snider
1.082 %
730,000 1.082 % 11 680 $

Company contact information

Nexien BioPharma, Inc.

4340 East Kentucky Avenue Suite 206

80246, Glendale

+303 495 7583

http://www.nexienbiopharma.com
address Kinder Holding Corp

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+29.68% 681B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.07% 556B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.35% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.65% 325B
ABBVIE INC. Stock AbbVie Inc.
+3.77% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.68% 235B
NOVARTIS AG Stock Novartis AG
+4.71% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-12.43% 189B
PFIZER, INC. Stock Pfizer, Inc.
-3.79% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. NXEN Stock
  4. Stock
  5. Company Kinder Holding Corp